Don Gabriel, M.D., Ph.D Medical Director
Dr. Gabriel was a Professor of Medicine at the University of North Carolina (UNC) at Chapel Hill, where he was a hematologist and bone marrow transplant physician for more than thirty years. He also served as Associate Chief of Staff, Assistant Dean for Clinical Services, Acting Chief of Medical Oncology, and Service Chief Liaison of the Division of Hematology/Oncology at UNC. His areas of expertise include oncology, hematology, and the application of physical methods such as light scattering to hemostasis and hematology.
Dr. Gabriel Received his MD from UNC as well as a PhD in Biophysical Chemistry. He completed an internal medicine residency at Massachusetts General Hospital, a Fellowship in Hematology at UNC and a stem cell transplant fellowship at the Fred Hutchinson Cancer Center in Seattle. He was a recipient of the Lineberger Cancer Center Distinguished Achievement Award. Dr. Gabriel has served as co- or principal investigator numerous clinical trials.
In addition, Dr. Gabriel has served as a clinical consultant to many leading pharmaceutical companies and is a founder of Invitrox Technologies.
Susan Fiscus, Ph.D, M.A. Laboratory Director
Dr. Fiscus received a B.S. from Bates College, M.A. from Duke University, and Ph.D. from Colorado State University. Before her retirement in 2014, she was Professor of Microbiology & Immunology and of Pathology & Laboratory Medicine at the University of North Carolina at Chapel Hill, Director of the UNC Clinical Retrovirology Laboratory, and Associate Director of the UNC Center for AIDS Research (CFAR) Virology Core Laboratory. From 2006-2013 she was the Central Laboratory Principal Investigator for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. She also served as a member of NIH’s Division of AIDS VQA Quality Assurance Committee, the Adolescent Trials Network DSMB, and as Protocol Virologist for P1077 – Promoting Maternal-Infant Survival Everywhere (PROMISE).
Her research at UNC focused on optimizing methods for the prevention of mother to child transmission of HIV and studying the effects of antiretrovirals and co-infections on the pathogenesis of HIV in compartments by measuring HIV in genital secretions, CSF, saliva, and breast milk. In addition, she evaluated novel methods to diagnose acute HIV infection, early infant diagnostics, and simpler, less expensive ways to monitor response to antiretrovirals in resource limited settings.
Regina Bowling, BSMT(ASCP) Laboratory Manager
Regina J. Bowling BSMT (ASCP) is the Laboratory Manager at Invitrox Technologies, a division of AIDIA Investment Group, Inc. She obtained a BS in Medical Technology from the University of North Carolina at Wilmington and Cape Fear Valley School of Medical Technology in Fayetteville, North Carolina. Regina has over 30 years of technical and supervisory experience with diagnostic, research, development, manufacturing, and CLIA laboratories.